Skip to main content

Impax Asset Management Group plc

SEC CIK
0001749768
Latest filing
Aug 11, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Impax Asset Management Group plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
272,358
Value
$24.7M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ABT by Impax Asset Management Group plc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026272,358$24.7M0.2%+65,789+31.8%AddedHolders
Q1 2026206,569$21.2M0.1%+78,379+61.1%AddedHolders
Q4 2025128,190$16.1M0.1%−282−0.2%ReducedHolders
Q3 2025128,472$17.2M0.1%−13,701−9.6%ReducedHolders
Q2 2025142,173$19.3M0.1%−5,450−3.7%ReducedHolders
Q1 2025147,623$19.6M0.1%−252,428−63.1%ReducedHolders
Q4 2024400,051$45.2M0.2%−157,557−28.3%ReducedHolders
Q3 2024557,608$63.6M0.3%+2,754+0.5%AddedHolders
Q2 2024554,854$57.7M0.2%−121,228−17.9%ReducedHolders
Q1 2024676,082$76.8M0.3%−200,169−22.8%ReducedHolders
Q4 2023876,251$96.4M0.4%+83,175+10.5%AddedHolders
Q3 2023793,076$76.8M0.3%+314,819+65.8%AddedHolders
Q2 2023478,257$52.1M0.2%+433,930+978.9%AddedHolders
Q1 202344,327$4.49M<0.1%+1,983+4.7%AddedHolders
Q4 202242,344$4.65M<0.1%−16,142−27.6%ReducedHolders
Q3 202258,486$5.66M<0.1%−1,300−2.2%ReducedHolders
Q2 202259,786$6.50M<0.1%−3,198−5.1%ReducedHolders
Q1 202262,984$7.46M<0.1%+5,690+9.9%AddedHolders
Q4 202157,294$8.06M<0.1%+574+1.0%AddedHolders
Q3 202156,720$6.70M<0.1%+152+0.3%AddedHolders
Q2 202156,568$6.56M<0.1%−110.0%ReducedHolders
Q1 202156,579$6.78M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.